Oligonucleotide Therapy Market - Antisense and RNA Interference Technologies Transforming Genetic Disease Treatment
Market Overview The global oligonucleotide therapy market is experiencing transformative growth driven by antisense oligonucleotide and RNA interference technology advancement, expanding genetic disease treatment options, and emerging approvals validating novel therapeutic modalities. The global oligonucleotide therapy market is projected to exceed USD 8 billion through 2030, fueled by rare...
0 Reacties 0 aandelen 8 Views 0 voorbeeld